Google: Analysts' Upgrades, Downgrades

Google 2010 estimates increased at FBR.
Author:
Publish date:

NEW YORK (TheStreet) -- CHANGE IN RATINGS

AthenaHealth

(ATHN) - Get Report

upgraded at Deutsche from Hold to Buy. Company has completed its accounting review and has a strong long-term growth outlook. $51 price target.

BlackRock

(BLK) - Get Report

upgraded at Credit Suisse to Outperform from Neutral on valuation and expected stronger earnings. Price target lifted to $280. 2010 and 2011 EPS estimates raised to $11.36 and $13.50, respectively.

Cummins

(CMI) - Get Report

upgraded at Sterne Agee from Neutral to Buy. $79 price target. Company had an upbeat analyst meeting and should begin returning more cash to investors.

Citrix Systems

(CTXS) - Get Report

upgraded at Goldman from Sell to Neutral. Stock also removed from the Conviction List. Company will be a big winner from desktop virtualization. $52 price target.

Diamond Offshore

(DO) - Get Report

downgraded at Credit Suisse to Underperform from Neutral on rising rig-on-rig competition. Price target reduced to $79 from $86. 2010 and 2011 EPS estimates lowered to $8.25 and $7.30, respectively.

Jack in the Box

(JACK) - Get Report

upgraded at Goldman from Neutral to Buy. $27 price target. Estimates also raised, as margins are near a bottom.

STOCK COMMENTS / EPS CHANGES

Autodesk

(ADSK) - Get Report

added to Conviction Buy List at Goldman Sachs. Company is in the early stages of operating margin improvement. $35 price target.

Albemarle

(ALB) - Get Report

target, estimates boosted at BofA/Merrill. ALB price target raised to $48 from $42 on polymer additives and catalysts. Estimates increased through 2012. Maintain Buy rating.

TD Ameritrade

(AMTD) - Get Report

estimates lowered at FBR through 2011. Company is seeing weaker trading activity. Outperform rating.

Abercrombie & Fitch

(ANF) - Get Report

numbers boosted at Jesup & Lamont. Shares of ANF now seen reaching $55. Estimates also raised, because of higher sales. Buy rating.

Ariad Pharmaceuticals

(ARIA)

estimate changed at Barclays. ARIA 2010 EPS estimate introduced at -$0.57. Maintain Overweight rating and $7 price target.

BioMarin

(BMRN) - Get Report

estimates, target boosted at UBS. Shares of BMRN now seen reaching $26. Estimates also raised, as GALNS data continues to come in positive. Buy rating.

Cummins

(CMI) - Get Report

target, estimates boosted at Barclays to $74 from $64 after positive analyst day. 2010 and 2011 EPS estimates raised to $2.50 and $4.25, respectively. Maintain Overweight rating.

Cummins

(CMI) - Get Report

cut from Conviction Buy List at Goldman. CMI was removed from the Conviction Buy List. Stock is up 39% since December, but should continue to benefit from new engine regulations. Buy rating and $68 price target.

Discover Financial

(DFS) - Get Report

estimate cut at Barclays. 2010 EPS estimate lowered to 50 cents following 1Q10 results. Maintain Overweight rating and $18 price target.

Emdeon

(EM)

estimates raised at UBS EM estimates were upped through 2011. Company winning new clearinghouse contracts. Buy rating and $22 price target.

Google

(GOOG) - Get Report

estimates increased at FBR. Its 2010 estimates were raised because of strength in the advertising market. Strong dollar is also helping the company. Outperform rating and $810 price target.

Goodrich

(GR)

estimates, target boosted at FBR. Shares of GR now seen reaching $80. Estimates also raised, because of improving industry fundamentals. Outperform rating.

Hartford Financial

(HIG) - Get Report

estimates cut at FBR through 2011. Company is selling new stock to pay back TARP. Market Perform rating and $29 price target.

Jacobs Engineering

(JEC) - Get Report

cut from Focus List at Goldman Sachs. Management believes that the award environment is becoming more positive. Sell rating and $35 price target.

Kimberly-Clark

(KMB) - Get Report

target, estimates cut at BofA/Merrill. KMB price target reduced to $70 from $75 on higher pulp costs. 2010 and 2011 EPS estimates lowered to $4.80 and $5.23, respectively. Maintain Buy rating.

Microsoft

(MSFT) - Get Report

estimates, target raised at Citigroup. Shares of MSFT now seen reaching, $32. Estimates also boosted, because of cost-cutting. Buy rating.

Virgin Media

(VMED)

target, estimates boosted at Credit Suisse. VMED price target lifted to $25 from $21. Good momentum for 2010. 2010 and 2011 EPS estimates raised to 17 cents and 60 cents, respectively. Maintain Outperform rating.

Williams Sonoma

(WSM) - Get Report

estimates upped at Goldman through 2011. Company is seeing better sales across the board. Neutral rating and $26 price target.

This article was written by a staff member of TheStreet.com.